Suppr超能文献

可调节经闭孔男性系统(ATOMS)失败相关临床结局及因素的多中心评估

Multicentered Assessment of Clinical Outcomes and Factors Associated With Failure of the Adjustable TransObturator Male System (ATOMS).

作者信息

Redmond Elaine J, Nadeau Genevieve, Tu Le-Mai, Doiron R Christopher, Steele Stephen S, Herschorn Sender, Locke Jennifer A, Maciejewski Conrad C, Dwyer Neil T, Campeau Lysanne, Carlson Kevin V, Rourke Keith F

机构信息

Division of Urology, University of Alberta, Edmonton, Alberta, Canada.

Division of Urology, Université Laval, Quebec, Canada.

出版信息

Urology. 2021 Feb;148:280-286. doi: 10.1016/j.urology.2020.09.045. Epub 2020 Nov 10.

Abstract

OBJECTIVE

To assess postoperative outcomes from the Adjustable TransObturator Male System (ATOMS) and identify factors influencing failure to achieve continence.

PATIENTS AND METHODS

A multicentered analysis was performed on all patients treated for postprostatectomy incontinence using the third-generation ATOMS at 9 Canadian tertiary referral centers. The primary outcome was continence (defined as requiring ≤1 pad postoperatively for patients requiring ≥2 pads preoperatively and 0 pads for those requiring 1 pad preoperatively). Secondary outcomes included improvement (>50% change in pad use), patient satisfaction, explantation, and postoperative complications.

RESULTS

Two hundred and eighty nine patients with a mean age of 68.9 years were analyzed. Pre-operatively mean pad per day use was 4.2 (1-12), 31.5% of patients reported severe incontinence (≥5 pads/day), 33.9% had concurrent radiotherapy and 19.4% had failed previous incontinence surgery. Overall continence rate was 73.3% (n = 212) at a mean follow-up of 19.6 months. More than eighty nine percent (89.3%) (n = 258) of patients experienced >50% improvement, 84.4% (n = 244) of patients were satisfied with the results of surgery. More than seven percent (7.9%) (n = 23) required device explantation. On multivariate Cox regression analysis, concurrent radiotherapy (hazard ratio [H.R.] 2.3, P < .001), diabetes (H.R. 2.2, P = .007) and increased pre-operative pad usage (H.R. 1.1, P = .02) were each associated with failure to achieve continence, while patient age (P = .60), obesity (P = .08), prior urethral stenosis (P = .56), and prior incontinence surgery (P = .13) were not. Radiation therapy was also associated with device explantation (H.R. 2.7, P = .02).

CONCLUSION

ATOMS is a safe and efficacious for treatment of postprostatectomy incontinence. However, patients with prior radiation, increased pre-operative pad use, or diabetes are less likely to achieve continence.

摘要

目的

评估可调节经闭孔男性系统(ATOMS)的术后效果,并确定影响控尿未成功的因素。

患者与方法

对加拿大9家三级转诊中心使用第三代ATOMS治疗前列腺切除术后尿失禁的所有患者进行多中心分析。主要结局是控尿(定义为术前需要≥2片尿垫的患者术后需要≤1片尿垫,术前需要1片尿垫的患者术后需要0片尿垫)。次要结局包括改善情况(尿垫使用量变化>50%)、患者满意度、取出装置以及术后并发症。

结果

分析了289例平均年龄为68.9岁的患者。术前平均每天使用尿垫4.2片(1 - 12片),31.5%的患者报告有严重尿失禁(≥5片/天),33.9%的患者同时接受了放疗,19.4%的患者既往尿失禁手术失败。平均随访19.6个月时,总体控尿率为73.3%(n = 212)。超过89.3%(n = 258)的患者改善情况>50%,84.4%(n = 244)的患者对手术结果满意。超过7.9%(n = 23)的患者需要取出装置。多因素Cox回归分析显示,同时接受放疗(风险比[H.R.] 2.3,P <.001)、糖尿病(H.R. 2.2,P =.007)和术前尿垫使用量增加(H.R. 1.1,P =.02)均与控尿未成功相关,而患者年龄(P =.60)、肥胖(P =.08)、既往尿道狭窄(P =.56)和既往尿失禁手术(P =.13)则无关。放疗也与取出装置相关(H.R. 2.7,P =.02)。

结论

ATOMS治疗前列腺切除术后尿失禁安全有效。然而,既往接受过放疗、术前尿垫使用量增加或患有糖尿病的患者控尿成功的可能性较小。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验